SIBN Profile
SI-BONE, Inc., a prominent medical device company, specializes in the development and commercialization of implantable devices designed to address musculoskeletal disorders of the sacropelvic anatomy. Operating both domestically and internationally, the company focuses on innovative solutions to treat conditions such as sacroiliac joint dysfunction, degeneration, adult deformity, and pelvic ring traumatic fractures. SI-BONE's flagship product is the iFuse system, a minimally invasive surgical implant that offers a solution for sacroiliac joint disorders, providing relief and restoring function through a less invasive approach.
The company's product portfolio includes the iFuse-3D, a titanium implant that enhances the traditional iFuse design with a proprietary 3D-printed porous surface and fenestrated structure. This advanced implant is engineered to improve integration with bone and support enhanced stability. Additionally, SI-BONE offers the iFuse-TORQ, a set of 3D-printed threaded implants designed for the treatment of pelvic fractures and minimally invasive sacroiliac joint fusion. These products leverage cutting-edge 3D printing technology to provide targeted solutions for complex musculoskeletal issues.
SI-BONE markets its products through a combination of direct sales and distribution networks, ensuring widespread accessibility and support for healthcare providers. The company's sales force is complemented by a network of distributors, allowing for effective outreach and comprehensive service in various global markets. This multi-channel approach helps the company cater to a diverse range of medical needs and patient populations.
Incorporated in 2008 and headquartered in Santa Clara, California, SI-BONE continues to advance the field of musculoskeletal care with its innovative implantable solutions. The company's commitment to research and development drives its mission to improve patient outcomes and enhance the quality of life for individuals suffering from complex sacropelvic conditions.
|
